Top

Cancer Causes & Control

Published in:

01-10-2006 | Original Paper

UV, latitude, and spatial trends in prostate cancer mortality: All sunlight is not the same (United States)

Authors: Gary G. Schwartz, Carol L. Hanchette

Published in: Cancer Causes & Control | Issue 8/2006

Abstract

Objective

We showed previously that Caucasian mortality rates from prostate cancer for 1970–1979 are significantly inversely correlated with ultraviolet (UV) radiation. We now present the analysis of prostate cancer mortality data over a 45-year period (1950–1994) in order to examine the persistence of this pattern. Furthermore, because vitamin D synthesis does not occur during winter months at latitudes higher than 40° N, we examined this relationship above and below 40° N latitude.

Methods

We used trend surface and linear regression analyses to characterize the relationship between prostate cancer mortality and UV radiation for U.S. counties at northern and southern latitudes.

Results

For U.S. Caucasians, prostate cancer mortality rates at the county and SEA levels followed a significant north–south spatial trend that is the inverse of UV radiation. We found significant inverse correlations between UV radiation and prostate cancer mortality at all time points over this 45-year period. These correlations were significantly more pronounced at locations north of 40° N latitude.

Conclusions

Our analyses confirm and extend our findings that the geographic distribution of prostate cancer mortality is the inverse of that of UV radiation. This effect is strongest in counties north of 40° N latitude, where vitamin D synthesis is limited to non-winter months. These findings add additional support for the hypothesis that vitamin D insufficiency increases risk for prostate cancer.

Yee, YK, Chintalacharuvu Lu, SR. J, Nagpal, S 2005Vitamin D receptor modulators for inflammation and cancerMini Rev Med Chem5761768PubMedCrossRef

Garland, CF, Garland, FC, Gorham, ED, et al. 2006The role of vitamin D in cancer preventionAm J Publ Health96252261CrossRef

Lim H-S, Roychoudhuri R, Peto J, Schwartz G, Baade P, Moller H (2006) Cancer survival depends on season of diagnosis and sunlight exposure. Int J Cancer (in press)

Giovannucci, E, Liu, Y, Rimm, EB, et al. 2006A prospective study of predictors of vitamin D status and cancer incidence and mortality in menJ Natl Cancer Inst98451459PubMedCrossRef

Haddad, JG,Jr 1973Natural and synthetic sources of circulating 25-hydroxyvitamin D in manNature244515517PubMedCrossRef

Barger-Lux, MJ, Heaney, RP, Dowell, S, Chen, TC, Holick, MF 1998Vitamin D and its major metabolites: serum levels after graded oral dosing un healthy menOsteoporos Int8222230PubMedCrossRef

Holick, MF 1997Photobiology of vitamin DFeldman, DGloriexux, FHPike, JW eds. Vitamin D1Academic PressSan Diego, CA3339

Zehnder, D, Bland, R, Williams, MC, McNinch, , et al. 2001Expression of 25-hydroxyvitamin D₃-alpha-hydroxylaseJ Clin Endocrinol Metab86888894PubMedCrossRef

Schwartz, GG, Whitlach, LW, Chen, TC, Lokeshwar, B, Holick, MF 1998Human prostate cells synthesize 1,25-dihydroxyvitamin D₃ from 25-hydroxyvitamin D₃ Cancer Epidemiol Biomarkers Prev7391395PubMed

10.

Barreto, A, Schwartz, GG, Woodruff, R, Cramer, SD 200025-Hydroxyvitamin D₃, the prohormonal form of 1,25-Dihydroxyvitamin D₃, inhibits the proliferation of primary prostatic epithelial cellsCancer Epidemiol Biomarkers Prev9265270PubMed

11.

Townsend, K, Evans, KN, Campbell, MJ, Colston, KW, Adams, JS, Hewison, M 2005Biological actions of extra-renal 25-hydroxyvitamin d-1-alpha-hydroxylase and implications for chemoprevention and treatmentJ Steroid Biochem Mol Biol97103109PubMedCrossRef

12.

Young, MV, Schwartz, GG, Wang, L, et al. 2004The prostate 25-hydroxyvitamin d-1α-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin DCarcinogenesis25967971PubMedCrossRef

13.

Hanchette, CL, Schwartz, GG 1992Geographic patterns of prostate cancer mortality: evidence for a protective effect of ultraviolet radiationCancer7028612869PubMedCrossRef

14.

Schwartz, GG 2005Vitamin D and the epidemiology of prostate cancerSem Dialysis18276289CrossRef

15.

Webb, AR, Kline, L, Holick, MF 1988Influence of season and latitude on the cutaneous synthesis of vitamin D₃. Exposure to winter sunlight in Boston and Edmonton will not promote vitamin D₃ synthesis in human skinJ Clin Endocrinol Metab67373378PubMedCrossRef

16.

Matsuoka, LY, Wortsman, J, Haddad, JG, Hollis, BW 1989In vivo threshold for the cutaneous synthesis of vitamin D₃J Lab Clin Med114301305PubMed

17.

National Oceanic and Atmospheric Administration (2002) UV radiation and UV index information. Available at http://www.cpc.ncep.noaa.gov/products/stratosphere/uv_index/uv_information.html

18.

McKenzie, R, Smale, D, Kotkamp, M 2004Relationship between UVB and erythemally weighted radiationPhotochem Photobiol Sci3252256PubMedCrossRef

19.

Devesa SS, Grauman DJ, Blot WJ, Pennello G, Hoover RN, Fraumeni JF Jr (1999)Atlas of cancer mortality in the United States, 1950–94. Washington, DC: US Govt Print Off; [NIH Publ No. (NIH) 99–4564]. Available at http://www3.cancer.gov/atlasplus/

20.

Kafadar, K 1997Geographic trends in prostate cancer mortality: an application of spatial smoothers and the need for adjustmentAnn Epidemiol73545PubMedCrossRef

21.

O’Sullivan, D, Unwin, DJ 2003Geographic information analysisJohn Wiley & Sons, IncHoboken, NJ256263

22.

Norcliffe, GB 1969On the use and limitations of trend surface modelsCan Geographer8338348CrossRef

23.

Schwartz, GG, Hulka, BS 1990Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis)Anticancer Res1013071311PubMed

24.

Scotto J, Fears TR, Gori GB (1974) Measurements from ultraviolet meters at ten locations in the United States during 1974 and comparisons with recent skin cancer data. DHEW Publ. No. (NIH) 76–1029. Bethesda, MD, National Cancer Institute, Division of Cancer Cause and Prevention

25.

Fears, TR, Scotto, J, Schneiderman, MA 1977Mathematical models of age and ultraviolet effects on the incidence of skin cancer among whites in the United StatesAm J Epidemiol105420427PubMed

26.

Jemal, A, Kulldorff, M, Devesa, SS, Hayes, RB, Fraumeni, JF,Jr 2002A geographic analysis of prostate cancer mortality in the United States, 1970–89Int J Cancer101168174PubMedCrossRef

27.

Boscoe, FP, McLaughlin, C, Schymura, MJ, Kielb, CL 2003Visualization of the spatial scan statistic using nested circlesHealth Place9273277PubMedCrossRef

28.

Rosner, B 1995Fundamentals of biostatistics4Duxbury PressBoston

29.

Calvo, MS 2003Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement useNutr Rev61107113PubMedCrossRef

30.

John, EM, Schwartz, GG, Koo, J, Berg, D, Ingles, SA 2005Sun exposure, vitamin D gene polymorphisms and risk of advanced prostate cancerCancer Res6554705479PubMedCrossRef

31.

Cleek, RK 1979Cancers and the environment: the effect of scaleSoc Sci Med13D241247

32.

Edwards, SM, Eeles, RA 2004Unraveling the genetics of prostate cancerAm J Med Genet129C6573CrossRefPubMed

33.

Jemal, A, Ward, E, Xiaocheng, W, Martin, HJ, McLaughlin, C, Thun, MJ 2005Geographic patterns of prostate cancer mortality and variations in access to medical care in the United StatesCancer Epidemiol Biomarkers Prev14590595PubMedCrossRef

34.

Lai, S, Lai, H, Krongrad, A, Roos, BA 2001Overall and disease-specific survival after radical prostatectomy: geographic uniformityUrology57504509PubMedCrossRef

35.

Etminan, M, Fitzgerald, JM, Gleave, M, Chambers, K 2005Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysisCancer Causes Control1611251131PubMedCrossRef

36.

Clark, LC, Cantor, KP, Allaway, WH 1991Selenium in forage crops and cancer mortality in U.S. countiesArch Environ Health463742PubMedCrossRef

37.

Chan, JM, Gann, PH, Giovannucci, EL 2006Role of diet in prostate cancer development and progressionJ Clin Oncol2381528160CrossRef

38.

Baron, JA, Beach, M, Wallace, K, et al. 2005Risk of prostate cancer in a randomized clinical trial of cancer supplementationCancer Epidemiol Biomarkers Prev14586589PubMedCrossRef

39.

Nileson, SJ, Popkin, BM 2004Changes in beverage intake between 1977 and 2001Am J Prev Med27205210CrossRef

40.

Amling, CL 2005Relationship between obesity and prostate cancerCurr Opin Urol15167171PubMedCrossRef

41.

Baskin, ML, Ard, J, Allison, DB 2005Prevalence of obesity in the United StatesObesity Rev657CrossRef

42.

Reisinger, M 2003Sectoral shifts and occupational migration in the United StatesProf Geogr55383395

43.

John, EM, Dreon, DM, Koo, J, Schwartz, GG 2004Residential sunlight exposure is associated with a decreased risk of prostate cancerJ Steroid Biochem Mol Biol89–90549552PubMedCrossRef

44.

Rogerson, PA, Sinha, G, Han, D 2006Recent changes in the spatial pattern of prostate cancer in the U.SAm J Prev Med30S509PubMedCrossRef

45.

Boscoe F (2006) The protective effect of sunlight exposure against colorectal and prostate cancer mortality. Paper presented at the 102nd annual meeting of the Association of American Geographers. Chicago, IL, March 9, 2006. Published abstract available at: http://communicate.aag.org/eseries/aag_org/program/AbstractDetail.cfm?AbstractID=8931

46.

Luscombe, CJ, French, ME, Siu, S, Saxby, MR, Jones, PW, Fryer, AA, et al. 2001Prostate cancer risk: associations with ultraviolet radiation, tyrosinase and melanocortin-1 receptor genotypesBr J Cancer8515041509PubMedCrossRef

47.

Walsh, PC, Worthington, JF 1995The prostate: a guide for menJohns Hopkins Uninversity PressBaltimore, MD

48.

Freedman, DM, Dosemeci, M, McGlynn, K 2002Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case–control studyOccup Environ Med59257262PubMedCrossRef

49.

Weinrich, S, Ellison, G, Weinrich, M, Ross, K, Reis-Starr, C 2001Low sun exposure and elevated serum prostate specific antigen in African American and Caucasian menAm J Health Stud17148150

50.

Tuohimaa, P, Tenkanen, L, Ahonen, M, et al. 2004Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case–control study in the Nordic countriesInt J Cancer108104108PubMedCrossRef

Title: UV, latitude, and spatial trends in prostate cancer mortality: All sunlight is not the same (United States)
Authors: Gary G. Schwartz
Carol L. Hanchette
Publication date: 01-10-2006
Publisher: Kluwer Academic Publishers
Published in: Cancer Causes & Control / Issue 8/2006
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-006-0050-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 8/2006

Body size and composition and prostate cancer risk: systematic review and meta-regression analysis

Relationship of alcohol intake and sex steroid concentrations in blood in pre- and post-menopausal women: the European Prospective Investigation into Cancer and Nutrition

Localized depletion: the key to colorectal cancer risk mediated by MTHFR genotype and folate?

Obesity and the risk of Hodgkin lymphoma (United Kingdom)

Racial and ethnic differences in lung cancer incidence: how much is explained by differences in smoking patterns? (United States)

Serum transforming growth factor-β1 levels and pancreatic cancer risk: a nested case–control study (Japan)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer